A ccumulation of apoptotic cells and necrotic debris within the lipid core is a major feature of advanced atherosclerotic lesions and has been associated with increased susceptibility to thrombotic complications after plaque rupture. [1] [2] [3] [4] We and others have shown that accumulation of apoptotic and secondary necrotic debris in atherosclerotic lesions results from defective efferocytosis or clearance of apoptotic cells. [3] [4] [5] This in turn leads to activation of immune-inflammatory responses and accelerates the progression of atherosclerosis. 3, 5, 6 Mouse models of decreased efferocytosis, such as mice lacking the receptor MERTK (myeloid-epithelial-reproductive tyrosine kinase) or the bridging molecule MFGE8 (milk fat globule EGF-like factor 8) showed an alteration of the protective immune response, associated with increased vascular inflammation and enhanced necrotic core formation. [7] [8] [9] However, the mechanisms involved in necrosis-induced inflammation during atherosclerosis development are not fully understood.
kinase) pathway. 10, 11 DNGR-1 is mostly expressed by the CD8α + subset of DCs (CD8α + DCs) as a receptor for necrotic cells, which favors cross-priming of cytotoxic T lymphocytes to dead cell-associated antigens in mice. 11 Although this receptor is not essential for particle uptake via phagocytosis, 11 DNGR-1 is capable of internalizing bound antigens via endocytosis and directing them to the endosomal vesicles for cross-presentation of dead cell-associated antigens by CD8α + DCs. 12, 13 Our hypothesis is that accumulation of apoptotic and necrotic debris during the development of atherosclerosis activates DNGR-1, leading to disease progression. Here, we show that DNGR-1 expression in hematopoietic cells and particularly in CD8α + DCs promotes atherosclerosis through downregulation of the anti-inflammatory and antiatherogenic cytokine, IL-10.
Methods
Detailed methods can be found in the Online Data Supplement. Cre+ (Jax). Mfge8 −/− mice were previously described. −/− male mice on either chow diet (20 weeks) or high-fat diet (HFD; 6 weeks) were used in some experiments. We subjected 7-to 10-week-old Ldlr -/-male mice to medullar aplasia by 9.5 gray lethal total body irradiation. We repopulated the mice with an intravenous injection of bone marrow cells isolated from femurs and tibias of age-and sex-matched C57Bl/6J mice: Clec9a ) mice. After 4 weeks of reconstitution, the mice were put on HFD diet for 7 weeks.
Animals

Il10
All mice used in these experiments were bred and housed in a specific pathogen-free barrier facility. Experiments were conducted according to the French veterinary guidelines and those formulated by the European community for experimental animal use (L358-86/609EEC).
Extent and Plaque Composition of Atherosclerotic Lesions
Quantification of lesion size and composition was performed as previously described.
15
Flow Cytometry
Flow cytometric analysis was performed on single cell suspensions of spleen and peritoneal cells as mentioned before. 16 
Cell Recovery and Stimulation
Cells were cultured in RPMI 1640 supplemented with Glutamax, 10% FCS, 0.02 mmol/L 2β-mercaptoethanol, and antibiotics. Splenocytes were stimulated with lipopolysaccharide (1 μg/mL; Sigma) for 48 hours, and then, supernatants were subjected to cytokine measurements. 
Novelty and Significance
What Is Known?
• Advanced atherosclerotic plaques are characterized by an increase in necrotic cells.
• A necrotic core increases plaque instability.
• The DNGR-1 (dendritic cell NK lectin group receptor-1) is involved in sensing necrotic cells.
What New Information Does This Article Contribute?
• The DNGR-1, specifically expressed by a subtype of dendritic cells (CD8α + DCs), has proinflammatory and proatherogenic effects that depend on interleukin-10.
• A new role of DNGR-1 in regulating vascular inflammation and atherosclerosis, making it a potential target that could be blocked to promote plaque stabilization.
Accumulation of necrotic debris increases inflammation in atherosclerotic lesions and has been associated with higher susceptibility to plaque rupture. However, the mechanisms that contribute to necrosis-induced inflammation during atherogenesis remain unclear. 
Statistical Analysis
Values are expressed as means±SEM. Differences between values were examined using Student t test. Mann-Whitney test is applied in the animal studies. Values were considered significant at P≤0.05.
Results
DNGR-1 Deficiency Decreases the Development of Atherosclerosis
To study the role of DNGR-1 in atherosclerosis, we crossed littermate controls. Both groups were put on chow diet until euthanasia at 20 weeks of age. As shown in Figure 1 , invalidation of DNGR-1 led to a marked 60% decrease of plaque size (P=0.002), despite no significant change in plasma cholesterol levels ( Figure 1A through 1C) . We also reconstituted lethally irradiated Ldlr −/− mice with Clec9a +/+ or Clec9a −/− bone marrow. After 4 weeks of recovery, mice were put on HFD for 5 or 7 weeks to study early disease stages and for 13 weeks to study advanced stages of atherosclerosis. As expected, plasma cholesterol levels significantly increased over time during HFD, without any significant differences between mice transplanted with Clec9a −/− or Clec9a +/+ bone marrow cells (Online Figure IA ). Mice reconstituted with Clec9a −/− bone marrow showed significant reduction in atherosclerosis at the aortic sinus ( Figure 1D and 1E) compared with mice reconstituted with Clec9a +/+ bone marrow after 5 or 7 weeks of HFD, confirming the atheroprotective effect of DNGR-1 deletion. Plaque area was also significantly decreased in the thoracic aorta after 7 weeks of HFD in mice reconstituted with Clec9a −/− compared with Clec9a +/+ bone marrow ( Figure 1F ). However, DNGR-1 deletion in bone marrow-derived cells had no effect on atherosclerosis in mice fed HFD for 13 weeks ( Figure 1D This was a surprising finding given that necrotic cores, which may activate signaling by DNGR-1, show increased accumulation in lesions at the advanced stages of atherosclerosis (Online Figure ID) . To account for that finding, we hypothesized that the absence of DNGR-1 proatherogenic effects after 13 weeks of HFD in Ldlr −/− mice or after HFD in Apoe −/− mice was because of the high plasma cholesterol levels observed in these mice, rather than of the advanced stage of the plaques.
We then examined Clec9a mRNA in the spleen, a tissue known to readily express Clec9a 17 and to play a major role in atherosclerosis. 18, 19 As shown in Online Figure IIA , Clec9a chimerism was high at all time points (7 or 13 weeks), as assessed by the almost total absence of Clec9a expression in Figure IIA ). This may suggest that Clec9a expression was downregulated by the prolonged and severe hypercholesterolemia after 13 weeks of HFD. Consistent with this hypothesis, in vitro incubation of splenocytes from Clec9a
Gfp/Gfp mice, in which the Clec9a gene was replaced by a GFP reporter gene (see Materials and Methods) in the presence of cholesterol markedly decreased GFP expression (Online Figure IIB) .
To investigate the role of Clec9a in advanced atherosclerosis while avoiding severe and prolonged hypercholesterolemia, we generated Clec9a 
DNGR-1 Mediates Proatherogenic Effects Through Downregulation of IL-10
We next assessed lesion composition in Clec9a +/+ at 7 weeks of HFD (P=0.047; Figure 2A ), but this effect was lost at 13 weeks of HFD (P=0.77; Figure 2B ) when plasma cholesterol levels were excessively high. bone marrow. The expression of major inflammatory cytokines involved in atherosclerosis, including Ifnγ, Il1β, and Il6 22 was not different between the 2 groups of mice after 7 weeks of HFD (Online Figure IVB) . However, as shown in Online Figure VA and VB and Figure 2C , DNGR-1 deficiency after 5 and 7 weeks, but not after 13 weeks of HFD, markedly increased Tgfβ and Il10 expression, suggesting an anti-inflammatory and antiatherogenic phenotype. [23] [24] [25] [26] We also found a significant increase of IL-10 production by splenocytes in the absence of DNGR-1 after lipopolysaccharide-TLR4 stimulation (Online Figure VC) , without significant changes in tumor necrosis factor-α or IL-6 (data not shown), suggesting that DNGR-1 acts as a regulator of IL-10.
To directly address the physiological relevance of enhanced expression of IL-10 by DNGR-1-deficient bone marrow cells, we generated Clec9a (Figure 3C  through 3E) . These data further demonstrate that the modulation of IL-10 expression is an important mechanism through which DNGR-1 mediates its proatherogenic effects.
DNGR-1 Expressed in CD8α
+ DCs Regulates IL-10 Production and Atherosclerosis Development DNGR-1 is highly expressed in CD8α + DCs. 11 However, the role of CD8α + DCs in atherosclerosis is still poorly understood. 28 
the 80% Cd11c
Cre+ /Irf8 flox/flox (CD45.2) bone marrow (Online Figure VIB; Figure 4A) Figure 4B ). As expected, DNGR-1 was barely expressed in purified CD8α − DCs from spleens of both groups of mice ( Figure 4B ). Reconstitution of spleen DCs, and more particularly CD8α + DCs, was similar between the 2 groups of mice (Online Figure VIC) .
Remarkably, the selective absence of DNGR-1 in CD8α + DCs significantly decreased plaque size (P=0.04; Figure 4C and 4D), despite no change in plasma cholesterol levels (6.69±0.25 versus 6.44±0.31 g/L; P=0.46). Moreover, macrophage and T-cell infiltration within the plaques were significantly decreased in the absence of DNGR-1 in CD8α + DCs, indicating that the expression of DNGR-1 in CD8α + DCs is required to mediate its proatherogenic effects (Online Figure  VIIA ; Figure 5A and 5B).
DNGR-1 has previously been shown to induce CD8 + T-cell responses against dying cells. 30 However, we found no differences in spleen CD8 + T-cell percentage or activation between the 2 groups of mice (Online Figure VIIB) , suggesting the involvement of other mechanisms.
Interestingly, as in the total DNGR-1-deficient model, the specific deletion of DNGR-1 in CD8α
+ DCs led to a marked increase of IL-10 expression in those cells (Online Figure  VIIC) but also more generally in the spleen ( Figure 5C) , showing that DNGR-1 specifically expressed by CD8α + DCs plays a major role in the regulation of IL-10. DNGR-1 was also detected in CD45 + cells purified from atherosclerotic plaque aorta (Online Figure VIIIA) , suggesting potential local effects. We also found higher Il10 mRNA levels in aortas of mice with DNGR-1 deletion in CD8α + DCs compared with controls, without significant changes of Tnfα, Il6, and Tgfβ expression (Online Figure VIIIB) .
The expression of Il10 in CD8α + DCs and DCs in general was relatively weak, which suggests that DNGR-1 deficiency in CD8α + DCs likely increased IL-10 expression in other cell types. Accordingly, it was previously shown that IL-10, and particularly DC-derived IL-10, promoted IL-10-producing T regulatory (Tr1) cells. 31, 32 In this regard, we found that coculture of splenic CD8α + DCs purified from Il10 −/− mice with 
Il10
−/− (n=9) mice. Then, the mice were put on HFD during 7 weeks. As shown in Figure 6A through 6D, specific IL-10 deletion in CD8α + DC abrogated the atheroprotection observed in absence of DNGR-1 in this cell type, without any significant change of plasma cholesterol levels. This was associated with the inability of Clec9a deficiency to increase IL-10 production by splenocytes ( Figure 6E ). Furthermore, coculture of CD8α + DCs from each group with wild-type CD4 + T cells showed that CD8α + DCs promoted increased IL-10 production by T cells in the absence of DNGR-1, which was dependent on IL-10 expression in CD8α + DC (Online Figure  XB) and most likely IL-10 receptor signaling in CD4 + T cells (Online Figure XC) .
Discussion
Accumulation of apoptotic cells or debris during the development of atherosclerosis promotes inflammation and contributes to plaque growth and thrombosis on plaque rupture. 5, 33 We recently showed that CLEC4e (C-type lectin receptor 4e), known to be involved in the sensing of necrotic cores, promoted atherosclerosis through induction of endoplasmic reticulum stress-dependent macrophage proliferation, inflammation, and foam cell formation. 34 However, other C-type lectin receptors could recognize necrotic cores and stimulate inflammation and plaque progression.
Our findings provide in vivo and in vitro evidence that DNGR-1, known to be involved in the sensing and presentation of antigens derived from necrotic cells, 12 is proatherogenic, 
and its deletion in both Ldlr
−/− and Apoe −/− mouse models promotes an anti-inflammatory response and deactivates important proatherogenic mechanisms. We have identified a new DNGR-1-regulated IL-10 pathway that controls vascular inflammation and substantially impacts lesion development. DNGR-1 deficiency inhibited macrophage and T-cell infiltration within the plaques and upregulated Tgfb and Il10, 2 major anti-inflammatory and antiatherogenic genes. 2, 25 Intriguingly, the atheroprotective effect of DNGR-1 deletion was already observed at the early stages of atherosclerosis (5 or 7 weeks of HFD) when plaques were still relatively small and apoptotic cell death was barely detectable. Even though we cannot rule out the possibility that DNGR-1 was activated by some necrotic debris, it is likely that other pattern recognition receptors, including TLRs, were activated during atherosclerosis 35 and interacted with DNGR-1 signaling to activate inflammatory pathways. In agreement with this, our results showed that the absence of DNGR-1 in splenocytes increased the production of the anti-inflammatory factor IL-10 after TLR4 stimulation.
After 13 weeks of HFD, we no longer observed differences in plaque size in the absence of DNGR-1, despite the presence of necrotic cores. Also, the atheroprotection observed in absence of DNGR-1 in Apoe −/− mice fed with chow diet was abrogated when the mice were put on HFD. We think that this was because of reduced Clec9a expression caused by the high plasma cholesterol levels, as indicated by our in vitro experiments showing reduced CLEC9a expression by CD8α + DCs in the presence of high cholesterol. In agreement with this, we found that DNGR-1 deletion was still atheroprotective in mice deficient for Mfge8, which exhibited after only 7 weeks of HFD (moderate hypercholesterolemia) increased accumulation of apoptotic/necrotic debris, and plaques as large as those found in Mfge8 +/+ mice after 13 weeks of HFD (severe hypercholesterolemia). In addition, previous studies showed that T cells become dispensable for atherosclerosis development after prolonged and severe hypercholesterolemia. 36, 37 More recently, Tsaousi et al 38 reported that when Apoe −/− mice were fed a chow diet for 35 weeks, lesions were approximately the same size as after 12 weeks of HFD. Yet, T-bet-deficient Apoe −/− mice, in which T cells are unable to differentiate into a Th1 phenotype, exhibited fewer plaques compared with immunocompetent Apoe −/− mice after 35 weeks of chow diet, whereas T-bet deficiency had no atheroprotective effects in Apoe −/− mice fed a HFD for 12 weeks. As our data suggest that the protective effects of DNGR-1 deletion are dependent on T cells, this may explain why the atheroprotective effect is lost at high plasma cholesterol levels.
In agreement with our hypothesis of a role for DNGR-1 in adaptive immune responses, earlier studies showed a restricted DNGR-1 expression in CD8α + DCs. 12,39 However, 28 However, flt3 −/− mice are also deficient for many other conventional DC subtypes. Moreover, in contrast to those results, atherosclerotic plaque formation and stability were not altered in chimeric Ldlr −/− mice transplanted with bone marrow from Batf3(basic leucine zipper transcription factor ATF-like 3)-deficient mice that lack the CD8α + DC subset, compared with Ldlr −/− mice transplanted with a control bone marrow. 29 Our study differs from the previous ones in that we report on the deletion of a specific pattern recognition receptor selectively expressed by CD8α + DCs, while preserving the other functions of this DC subset. Our present results clearly indicate that the specific deletion of DNGR-1 in CD8α + DCs promotes atherosclerosis, identifying a previously unrecognized proatherogenic function of CD8α + DCs in the development of atherosclerosis.
DNGR-1 stimulation in CD8α + DCs has been previously shown to mediate cross-presentation of dead cell-associated antigens leading to CD8 + T-cell activation. 11, 40 Thus, we expected that DNGR-1 expressed in CD8α
+ DCs under conditions of hyperlipidemia would lead to CD8 + T-cell activation. However, our results showed no significant changes in spleen CD8 + T-cell count or activation between control and DNGR-1-deficient mice, suggesting that cross-presentation may not be the main mechanism accounting for DNGR-1-mediated proatherogenic effects. In addition, the role of CD8 + T cells and cross-presentation in atherosclerosis is still debated. 29, [41] [42] [43] Interestingly, we found that DNGR-1 deletion in CD8α + DCs increased the expression of the anti-inflammatory and antiatherogenic IL-10 in spleens, suggesting the involvement of this cytokine in the observed atheroprotective effects. Noteworthy, spleen CD8α + DCs purified from mice reconstituted with DNGR-1-deficient CD8α + DCs showed a significantly higher IL-10 expression compared with control CD8α + DCs. Yet, IL-10 expression by CD8α + DCs was weak, suggesting an additional impact of DNGR-1 deficiency in CD8α + DCs on IL-10 expression in other cell types. In agreement with this, we found that the absence of DNGR-1 in CD8α + DCs led to increased IL-10 (but not IL-17 nor interferon-γ) production by CD4 + T cells, suggesting the induction of an anti-inflammatory and antiatherogenic T-cell response.
Our findings point to an important role of IL-10 as the main atheroprotective factor in the absence of DNGR-1. First, IL-10 expression was upregulated at 5 and 7 weeks of HFD in the absence of DNGR-1. However, after 13 weeks of high diet, when no difference of plaque size was observed, IL-10 expression remained unchanged in the absence of DNGR-1. Moreover, double deficiency in DNGR-1 and IL-10, specifically in CD8α + DCs, completely abrogated the protective effects of DNGR-1 deletion. The mechanisms leading to an increase of IL-10 in the absence of DNGR-1 are still unknown and will require further investigation. One likely mechanism is that interaction between TLRs and DNGR-1 signaling modulates IL-10 production through the SYK pathway. 10, 11, 44, 45 In conclusion, our results identify a proatherogenic role for the necrotic cell sensor DNGR-1 through the regulation of IL-10 production and suggest a new potential therapeutic target to combat atherosclerosis.
